Cargando…
Inhaled Corticosteroids Is Not Associated with the Risk of Pneumonia in Asthma
The introduction of inhaled corticosteroids (ICS) for the management of asthma has led to a decrease in acute exacerbation of asthma. However, there are concerns regarding the safety of long-term ICS use, particularly pneumonia. Growing evidence indicates that ICS use is associated with an increased...
Autores principales: | Lee, Ye Jin, Park, Yong-Bum |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323202/ https://www.ncbi.nlm.nih.gov/pubmed/36950897 http://dx.doi.org/10.4046/trd.2022.0147 |
Ejemplares similares
-
Inhaled Corticosteroids in Asthma and the Risk of Pneumonia
por: Kim, Min-Hye, et al.
Publicado: (2019) -
Risk of Pneumonia Associated With the Use of Inhaled Corticosteroids in Asthma
por: Kim, Sang-Heon
Publicado: (2019) -
Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia
por: Ekbom, Emil, et al.
Publicado: (2019) -
Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma
por: Toogood, John H
Publicado: (2005) -
Protective effect of inhaled corticosteroid on children with asthma with Mycoplasma pneumoniae pneumonia
por: Wei, Bing, et al.
Publicado: (2022)